This spring, the federal machinery to get updated Covid shots ready for the fall appeared to be on track: A Food and Drug Administration advisory committee had taken the first step to prepare for the new shots, selecting the latest strains to target. The agency accepted the panel’s recommendations and passed the message along to vaccine makers.